EUVIMEDEUVIMED entdecken
Open Access

Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat

Chunxiang Wu iD, Megan E Meuser, Juan S Rey iD, Hamed Meshkin, Rachel Yang, Swapnil C Devarkar, Christian Freniere iD, Jiong Shi, Christopher Aiken, Juan R Perilla iD, Yong Xiong iD

Journal of the American Chemical Society · 06.11.2025

DOI: 10.1021/jacs.5c13735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 06.11.2025. Verfasst von Chunxiang Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511, United States. Hauptthemen laut MEDLINE: HIV-1, Anti-HIV Agents, Succinates, Pyrazines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Anti-HIV AgentsSuccinatesPyrazinesCryoelectron MicroscopyHumansCyclopropanesModels, MolecularBinding SitesAcetamidesIndazolesPentacyclic Triterpenes

Substanzen

Anti-HIV AgentsbevirimatCyclopropanesSuccinatesPyrazineslenacapavirAcetamidesIndazolesPentacyclic Triterpenes

Autor:innen und Institutionen

  • Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06511, United States.
  • Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.
  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.

ORCID-Profile: Chunxiang Wu, Juan S Rey, Christian Freniere, Juan R Perilla, Yong Xiong

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIH Office of the Director
  • Biological and Environmental Research
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Wu, C., Meuser, M. E., Rey, J. S., Meshkin, H., Yang, R., Devarkar, S. C., Freniere, C., Shi, J., Aiken, C., Perilla, J. R., & Xiong, Y. (2025). Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c13735

Vancouver

Wu C, Meuser ME, Rey JS, Meshkin H, Yang R, Devarkar SC, et al. Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c13735

BibTeX
@article{Wu2025,
  author = {Wu, Chunxiang and Meuser, Megan E and Rey, Juan S and Meshkin, Hamed and Yang, Rachel and Devarkar, Swapnil C and Freniere, Christian and Shi, Jiong and Aiken, Christopher and Perilla, Juan R and Xiong, Yong},
  title = {Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.5c13735}
}
Kostenlos starten →